Thursday, June 21, 2007

Monogram Biosciences stock: Panic selling after news of delayed Pfizer HIV drug

Perhaps the initial panic selling of Monogram Biosciences stock this morning shouldn't be surprising. Monogram manufactures a diagnostic test used to identify HIV patients who would respond to Pfizer Inc's maraviroc drug, which didn't get the expected FDA approval on June 20.

mgrmpn777

2 comments:

Anonymous said...

dr. rost,
any interesting mail this past weekend?

Anonymous said...

hmmm cryptic...I know everyone knows Pfizer has been propping Monogram up for quite awhile so in reality what you have is a paper tiger without Pfizer they may be caput....